Plunkett Research Online: Cosmo Pharmaceuticals

COSMO PHARMACEUTICALS (CMOPF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cosmo Pharmaceuticals NV is a major drug manufacturing company with a focus on specialty pharmaceuticals. Its clinical development pipeline maintains a focus on treatments for inflammatory bowel disease, colorectal cancer diagnosis, and colonoscopy. The company's business model involves identifying .....



Cosmo Pharmaceuticals
Ticker: CMOPF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 353 18170370
Fax:
Address: Sir John Rogerson’s Quay
Riverside II
Dublin, 2 Ireland

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

Cosmo Pharmaceuticals NV is a major drug manufacturing company with a focus on specialty pharmaceuticals. Its clinical development pipeline maintains a focus on treatments for inflammatory bowel disease, colorectal cancer diagnosis, and colonoscopy. The company's business model involves identifying .....See More See More

Auditor: BDO Audit & Assurance B.V
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: